Ladenburg Thalmann Financial Services’s Pacific Biosciences PACB Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-700	Closed	-$2K	–	5169
2017 Q4	$2K	Hold	700	–	–	﹤0.01%	4796
2017 Q3	$4K	Hold	700	–	–	﹤0.01%	4485
2017 Q2	$2K	Hold	700	–	–	﹤0.01%	4613
2017 Q1	$4K	Hold	700	–	–	﹤0.01%	4384
2016 Q4	$3K	Hold	700	–	–	﹤0.01%	4431
2016 Q3	$6K	Hold	700	–	–	﹤0.01%	4083
2016 Q2	$5K	Buy	700 +400	+133%	+$3.65K	﹤0.01%	4140
2016 Q1	$3K	Buy	+300	New	+$2.95K	﹤0.01%	4270
2015 Q1	–	Sell	-14,000	Closed	-$110K	–	4628
2014 Q4	$110K	Buy	+14,000	New	+$89.6K	﹤0.01%	1830

Other funds holding PACB

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return